Biomarkers for Drug Discovery & Development | Whitepapers & Reports
Development and Validation of Five Idiopathic Pulmonary Fibrosis (IPF) Biomarker Panels Comprising 12 Immunoassays: Advancing Clinical Diagnostic, Pharmacodynamic and Disease Activity Assessments in IPF
12 March 2024
Related Online Activities
Join the conversation with our upcoming Monthly Science Exchanges and Webinars:Subscribe to our newsletter
Sign up for our monthly Newsletter to keep up with all things Biomarkers